[Early diagnosis of and therapy for patients with diabetic nephropathy].
Makino
Hirofumi
H
D000419:Albuminuria / Q000652:urine; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D015415:Biomarkers / Q000652:urine; D001713:Biphenyl Compounds; D024141:Collagen Type IV / Q000652:urine; D003928:Diabetic Nephropathies / Q000175:diagnosis* / Q000628:therapy*; D018753:Diet, Protein-Restricted; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008019:Life Style; D017706:Lisinopril / Q000627:therapeutic use; D013777:Tetrazoles / Q000627:therapeutic use
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D015415:Biomarkers; D001713:Biphenyl Compounds; D024141:Collagen Type IV; D007004:Hypoglycemic Agents; D007328:Insulin; D013777:Tetrazoles; D017706:Lisinopril; C081643:candesartan